Skip to main navigation menu Skip to main content Skip to site footer

Comparación en el manejo de pacientes con degeneración mixomatosa mitral con enalapril o con la combinación enalapril-espironolactona

Comparación en el manejo de pacientes con degeneración mixomatosa mitral con enalapril o con la combinación enalapril-espironolactona



How to Cite
Comparación en el manejo de pacientes con degeneración mixomatosa mitral con enalapril o con la combinación enalapril-espironolactona. (2007). NOVA, 5(7). https://doi.org/10.22490/24629448.372

Dimensions
PlumX
license

Licencia Creative Commons

NOVA by http://www.unicolmayor.edu.co/publicaciones/index.php/nova is distributed under a license creative commons non comertial-atribution-withoutderive 4.0 international.

Furthermore, the authors keep their property intellectual rights over the articles.

 

Mauricio Ortega
    Leonardo Gómez

      The behavior of 45 canine patients with degeneration to valvular mixomatosa mitral, handled with a combinationenalapril- espironolactona (20) or enalapril (25) were evaluated in three occasions during 12 months, making apursuit of survival, serum levels of aldosterone (marking), creatinine, ureico nitrogen in blood, sodium and potassium.

      It was observed that aldosterone has a reduction in the serum levels subsequent to the treatment with enalapriland espironolactona far beyond the treated solely with enalapril, but in the last evaluation, they increase the levelsover the initial values, which suggests they already have activated other routes for the synthesis from the aldosterone,which are not mediated by angiotensin II and therefore they do not respond suitably to converter enzymes of angiotensin. The benefit of the combination with espironolactone is based on its selective blocking a selective of thealdosterone receivers, which would diminish its lethal action on the myocardium and the blood vessels.


      Article visits 147 | PDF visits 93


      Downloads

      Download data is not yet available.
      1. Amezquita, K. Romero, A. Determinación y correlación de los niveles de aldosterona sérica con la función ventricular en pacientes caninos cardiópatas y pacientes caninos sanos en la ciudad de Bogotá. Tesis de grado. Universidad de la Salle. 2006.
      2. Guyton A. Textbook of Medical Physiology. Ed. 11 Elservier. 2006.
      3. Sisson D. Neruoendocrine evaluation of cardiac disease. En: Veterinary Clinics: Small animal practice. Septiembre 2004.
      4. Galvan T. Insuficiencia cardiaca: datos para el debate. Panamericana. 2003.
      5. Belerenian G. Mucha C. Camacho J. Aparecido A. Afecciones cardiovasculares en pequeños animales. Ed. Intermédica, 2001.
      6. Kittleson M. Small animal cardiovascular medicine. Ed. Mosby.1998.
      7. Harrison T. Principios de medicina interna. Mc Graw-Hill-Interamericana. Ed.14.1998.
      8. -----------------------------------------------------------------------------------
      9. DOI: http://dx.doi.org/10.22490/24629448.372
      Sistema OJS 3.4.0.5 - Metabiblioteca |